PALD1 and colorectal cancer: In order to highlight the clinical significance of our discovery, we took advantage of the pan-cancer TCGA colorectal cancer dataset [9] and segregated 222 patient tumours according to median paladin mRNA expression, expressed as Z-score relative to all samples.